GSK sues Pfizer over RSV vaccine patents

By Agence France-Presse

Aug 04, 2023 12:13 am

NEW YORK CITY: GlaxoSmithKline sued Pfizer on Wednesday over patent infringement, alleging the US drugmaker's RSV vaccine steals key elements of the British company's version.

The case, filed in federal court in the state of Delaware, pits the producers of the only two approved vaccines for respiratory syncytial virus (RSV) against each other.

Already have an active account? Log in here to continue reading.
Or
Subscribe to the Premium Subscription plan to access this subscriber-exclusive article.

Related Articles

China's Nov indus-trial profits down by 7.3%

HK home prices edge up 0.07% in No-vember

US shoppers boost holiday spending 3.8%

Inflation in Japan's capital accelerates

New US unemployment benefit claims tumble

Oil prices edge higher in thin holiday trading

Japan's budget to hit record $735 billion